" /> Acalabrutinib/Obinutuzumab/Venetoclax Regimen - CISMeF





Preferred Label : Acalabrutinib/Obinutuzumab/Venetoclax Regimen;

NCIt synonyms : Acalabrutinib-Obinutuzumab-Venetoclax; Acalabrutinib/Obinutuzumab/Venetoclax; Obinutuzumab/Venetoclax/Acalabrutinib; Calquence/Gazyva/Venclexta Regimen; Venetoclax/Acalabrutinib/Obinutuzumab; Acalabrutinib/Venetoclax/Obinutuzumab; Venetoclax/Obinutuzumab/Acalabrutinib; Venclexta/Calquence/Gazyva; Obinutuzumab/Acalabrutinib/Venetoclax;

NCIt definition : A regimen consisting of acalabrutinib, obinutuzumab and venetoclax that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.